ENTITY
Resmed Inc

Resmed Inc (RMD US)

80
Analysis
Health Care • United States
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
more
bullish•Woodside Energy Group
•20 Oct 2025 04:30

Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (20 Oct)

​Statistical methodology identifies eleven pair trade opportunities across three markets and seven sectors, offering unique insights into relative...

Logo
634 Views
Share
•14 Oct 2025 05:59

Long F&P Health (FPH AU) Vs. Short ResMed (RMD AU): Pair Trade with 7% Upside Potential

The price-ratio between Fisher & Paykel Health and ResMed has diverged by 2 standard deviations, offering a potential relative value opportunity...

Logo
348 Views
Share
bearish•BHP Group Ltd
•12 Oct 2025 16:16

BHP (BHP AU/US) And Woodside (WDS AU/US) Slide as U.S. Sell-Off Spills Into Australian Stocks

Friday’s U.S. market rout pushed dual-listed Australian stocks lower, with BHP and Woodside among the biggest movers. US-traded ADRs and futures...

Logo
830 Views
Share
bullish•Cochlear Ltd
•26 Sep 2025 08:30

Cochlear Ltd (COH AU): Earnings Recovery to Continue on Nucleus Nexa Implant Launch

​Cochlear anticipates strong revenue growth in FY26 driven by new Nucleus Nexa System launch, with expected 11-17% increase in underlying net...

Logo
856 Views
Share
bullish•ResMed
•23 Sep 2025 10:46

Primer: ResMed (RMD UN) - Sep 2025

Market Leader Capitalizing on Favorable Industry Dynamics: ResMed is a global leader in the sleep and respiratory care market, poised to...

Share
x